30.02

3.02% 0.88

After Hours: 30.02

Staar Surgical Co (STAA)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Staar Surgical Co stock is traded at $30.02, with a volume of 454.68K. It is up +3.02% in the last 24 hours and down -14.40% over the past month. Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.

Previous Close:

$29.14

Open:

$28.99

24h Volume:

454.68K

Relative Volume:

0.56

Market Cap:

$1.45B

Revenue:

$326.24M

Net Income/Loss:

$15.30M

P/E Ratio:

76.97

EPS:

0.39

Net Cash Flow:

$20.88M

1W Performance:

-0.89%

1M Performance:

-14.40%

6M Performance:

-34.04%

1Y Performance:

-20.60%

1-Day Range:

$28.54

$30.05

1-Week Range:

$27.72

$31.35

52-Week Range:

$26.66

$52.68

Staar Surgical Co Stock (STAA) Company Profile

Name

Staar Surgical Co

Sector

Healthcare (1182)

Industry

Medical Instruments & Supplies (58)

Phone

(626) 303-7902

Address

1911 WALKER AVE, MONROVIA, CA

Employee

1,115

Twitter

@visianicl

Next Earnings Date

2024-10-30

Latest SEC Filings

STAA's Discussions on Twitter

Staar Surgical Co Stock (STAA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-11-24	Upgrade	Stifel	Hold → Buy
Dec-05-23	Downgrade	Needham	Buy → Hold
Dec-04-23	Initiated	Morgan Stanley	Equal-Weight
Sep-15-23	Downgrade	The Benchmark Company	Buy → Hold
Aug-03-23	Downgrade	Canaccord Genuity	Buy → Hold
Jun-07-23	Downgrade	William Blair	Outperform → Mkt Perform
Apr-17-23	Initiated	Piper Sandler	Neutral
Feb-06-23	Downgrade	BTIG Research	Buy → Neutral
Dec-28-22	Reiterated	BTIG Research	Buy
Dec-08-22	Initiated	Stifel	Hold
Nov-07-22	Upgrade	Sidoti	Neutral → Buy
Oct-14-22	Resumed	Stephens	Overweight
Oct-13-22	Initiated	Mizuho	Buy
Apr-08-22	Initiated	Needham	Buy
Mar-28-22	Upgrade	The Benchmark Company	Hold → Buy
Mar-18-22	Upgrade	BTIG Research	Neutral → Buy
Jul-09-21	Initiated	Oppenheimer	Perform
Jan-19-21	Downgrade	The Benchmark Company	Buy → Hold
Oct-26-20	Downgrade	Sidoti	Buy → Neutral
Aug-31-20	Upgrade	Sidoti	Neutral → Buy
Aug-06-20	Reiterated	The Benchmark Company	Buy
Jul-06-20	Downgrade	Sidoti	Buy → Neutral
Jun-24-20	Downgrade	BTIG Research	Buy → Neutral
Jun-15-20	Initiated	Jefferies	Buy
Dec-04-19	Initiated	BTIG Research	Buy
Sep-24-18	Reiterated	The Benchmark Company	Buy
Aug-06-18	Resumed	The Benchmark Company	Buy
Nov-20-17	Reiterated	The Benchmark Company	Buy
Aug-14-17	Reiterated	The Benchmark Company	Buy
Mar-03-17	Reiterated	The Benchmark Company	Buy
May-18-16	Upgrade	The Benchmark Company	Hold → Buy
Sep-10-13	Resumed	The Benchmark Company	Buy
Feb-28-13	Reiterated	The Benchmark Company	Buy
Nov-01-12	Downgrade	Canaccord Genuity	Buy → Hold
Mar-02-12	Initiated	Northland Securities	Outperform
Oct-25-11	Reiterated	The Benchmark Company	Buy
Oct-12-10	Initiated	Morgan Joseph	Buy
May-11-10	Initiated	Benchmark	Buy

View All

Staar Surgical Co Stock (STAA) Latest News

Nov 04, 2024